The purpose-built facility has been developed to meet the growing demand for advanced clinical trial supply services
Klifo, an independent provider of Clinical Trial Supply (CTS) packaging and distribution services, has received official Manufacturing and Importation Authorisation from the Danish Medicines Agency for its new Abildager facility in Copenhagen.
The purpose-built facility has been developed to meet the growing demand for advanced clinical trial supply services and includes:
- Expanded capacity to support small-scale studies through global Phase III and post-marketing trials
- Comprehensive temperature management from controlled room temperature to -80°C for storage, primary and secondary packaging, and distribution
- Low-light capabilities for light-sensitive products
René Pedersen, CEO, Klifo, said, "Approval of our new facility represents a major step forward for Klifo, and the site has already attracted significant interest from Nordic and international clients, reinforcing Copenhagen’s position as a leading life science hub in Europe. We can now offer even greater capacity to meet complex clinical trial supply chain needs globally while maintaining our focus on quality, compliance, and flexibility."
Klifo is able to accelerate project setup, decrease turnaround times and reduce clinical supply chain issues due to its new facility, experienced team, international reach, flexible solutions and compliance with global requirements.
